Volume 89 Issue 36 | p. 29 | Concentrates
Issue Date: September 5, 2011

Merck Millipore Will Acquire Amnis

Department: Business
News Channels: Analytical SCENE, Biological SCENE

Merck Millipore, the life sciences division of Germany’s Merck KGaA, will acquire Amnis, a Seattle-based maker of high-speed cell-imaging instrumentation. Using the acquired technology, Millipore will combine flow cytometry and imaging analysis in a single system. Amnis has 40 employees and had sales of $14 million last year. “With Amnis we acquire a business with a talented workforce, a strong intellectual property position, and unique know-how,” says Jonathan DiVincenzo, head of Merck Millipore’s bioscience business.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment